Investing.com alternatives
Investing.com is a news portal.
Its screener is buried
and limited.
Investing.com is one of the most-visited financial sites in the world — macro data, economic calendars, news, and rates. Its stock screener is a secondary feature, and fundamental data for European small caps is unreliable. If filter-driven equity screening is your primary workflow, these alternatives are built specifically for that.
Updated June 2026 · 5 alternatives reviewed
What a dedicated screener gives you over Investing.com
Screener as the product
Investing.com is designed around news, macro, and rates. The screener is a tab inside a portal. ScreenerHero is designed around the screener — every decision in the product exists to make filtering faster and results more actionable.
Reliable EU small cap data
Fundamental data for European small caps and microcaps on Investing.com is often incomplete or stale. ScreenerHero's pipeline covers all European exchanges — BME, XETRA, Euronext, Borsa Italiana — with consistent fundamental data.
Dense, sortable output
Screening results should be a table with dozens of columns you can sort instantly. Not a paginated list with limited columns and no density.
Free core screener
Test the actual filter depth and European coverage before paying anything. No account required for the core screener.
What to look for in an Investing.com alternative
Screener as the primary product
Is the screener the core of the tool, or a tab inside a news and macro portal? The quality of the screening experience depends on this.
European small cap fundamental coverage
P/E, ROE, EV/EBITDA, and balance sheet data for European small and microcap names — are they populated and current, or sparse and stale?
Filter depth
How many filters can you combine simultaneously? Can you filter by fundamentals, technicals, and geography at the same time without plan restrictions?
Output density
Results should be a sortable table with dozens of columns — not a card layout or a paginated list with five visible columns.
No news tax
You should not pay for news aggregation, macro calendars, or analyst reports when what you need is a screener. Match the cost to your actual workflow.
The 5 best Investing.com alternatives for stock screening (2026)
ScreenerHero
Screening-first. US + Canada + all of Europe. Dense, fast, decision-oriented.
ScreenerHero is built around the screener — not news, not macro charts, not a portal. Filter by 40+ fundamental and technical criteria across US, Canadian, and all European equities simultaneously. Results land in a dense, sortable table. European microcaps and illiquid names are first-class citizens, not afterthoughts. Free core screener with no account required. Pro at €29/month.
Markets
US, Canada, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, built around the screener
Heatmap
Yes
Finviz
The benchmark for dense US screening — no meaningful European coverage
Finviz is the reference standard for dense, fast filter-driven screening — and it is built entirely around the screener, not news or macro. Elite at $39.50/month adds real-time data and saved screens. US-only coverage is the core limitation: European exchanges are not part of the product. For anyone screening US equities, Finviz is the benchmark.
Markets
US primarily
Screener filters
P/E, P/B, ROE, margins, momentum — US equities only
UI style
Desktop-first, data-dense, screener-first
Heatmap
Yes
Stockopedia
Score-driven research for European equities — expensive, no US
Stockopedia is a screener and research platform with a respected quality/value/momentum composite (StockRanks). The product is built around equities — not news. Coverage is European with a UK bias; no Canadian equities. Continental European microcap coverage has gaps. At €60–80/month it is significantly more expensive than ScreenerHero.
Markets
UK-weighted, some continental Europe (no Canada)
Screener filters
StockRanks composite (QVM) + custom filters
UI style
Card-based, research-oriented
Heatmap
No
TIKR
Broad global coverage — screener-first at the right price
TIKR has broad global reach at an aggressive price point — $10–15/month for Plus. The product is built around equities and fundamentals, not news. European microcap coverage is a known gap. The UI is less dense than Finviz or ScreenerHero, and the Pro tier runs $40–55/month for historical depth and transcripts.
Markets
100k+ stocks, 92 countries
Screener filters
Fundamentals, historical financials, transcripts on Pro
UI style
Data-focused, less dense UI
Heatmap
No
MarketScreener
Deep European fundamental data — news-first, screener secondary
MarketScreener, like Investing.com, leads with news and analyst reports. The screener has 300–600 filters and broad European fundamental data, but the interface is dated and slow. At $30–34/month, it is cheaper than most alternatives reviewed here — but the workflow is news-first, not decision-oriented screening.
Markets
Europe and global
Screener filters
300–600 filters including analyst estimates
UI style
Table-based, slow, built around analyst reports
Heatmap
No
Quick comparison
| ScreenerHero | Investing.com | Finviz | Stockopedia | TIKR | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap EU coverage | |||||
| Screener-first UX | |||||
| Dense table UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Price/mo (from) | €29 | Free | $39.50 | €60 | $10 |
Recommendation by use case
You want to screen US, Canadian, and European stocks by fundamentals simultaneously
ScreenerHero — €29/mo, screening-first, full EU microcap depth, free core screener with no account required.
You need macro data, news, and an economic calendar alongside occasional screening
Investing.com — the free tier covers the macro workflow well. Accept the screener as a secondary, limited feature.
You screen US stocks only and want maximum density
Finviz — the benchmark for dense US screening, $39.50/month for Elite.
You invest in European equities and prefer composite scores over raw filters
Stockopedia — StockRanks is well-regarded for UK and European equities. Accept the €60–80/month price and coverage limits.
You want broad global coverage at the lowest price point
TIKR Plus — $10–15/month, wide global reach, accept European microcap gaps and less dense UI.
Built for screening. Not for news.
Dense tables. Fast filters. Heatmap. US, Canadian, and European equities — including microcaps — in one screening-first tool. Free, no account needed. Pro at €29/month.